These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22044642)

  • 1. The influence of systemic therapy on the serum levels of IL-6 and IL-8 in pemphigus vulgaris.
    Mortazavi H; Babaeijandaghi F; Akbarzadeh M; Rezaei N; Amirzargar AA; Daneshpazhooh M; Jalali A; Hallaji Z
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):387-90. PubMed ID: 22044642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of conventional immunosuppressive therapy on cytokine serum levels in pemphigus vulgaris patients.
    Mortazavi H; Esmaili N; Khezri S; Khamesipour A; Vasheghani Farahani I; Daneshpazhooh M; Rezaei N
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):174-83. PubMed ID: 24659121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production.
    Bhol KC; Desai A; Kumari S; Colon JE; Ahmed AR
    Clin Immunol; 2001 Aug; 100(2):172-80. PubMed ID: 11465946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity.
    D'Auria L; Bonifati C; Mussi A; D'Agosto G; De Simone C; Giacalone B; Ferraro C; Ameglio F
    Eur Cytokine Netw; 1997 Dec; 8(4):383-7. PubMed ID: 9459618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
    Bhol KC; Rojas AI; Khan IU; Ahmed AR
    Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared to conventional immunosuppressive therapy.
    Keskin DB; Stern JN; Fridkis-Hareli M; Razzaque Ahmed A
    Cytokine; 2008 Mar; 41(3):315-21. PubMed ID: 18289869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-intercellular substance antibody log titres are correlated with serum concentrations of interleukin-6, interleukin-15 and tumor necrosis factor-alpha in patients with Pemphigus vulgaris relationships with peripheral blood neutrophil counts, disease severity and duration and patients' age.
    Ameglio F; D'Auria L; Cordiali-Fei P; Trento E; D'Agosto G; Mastroianni A; Giannetti A; Giacalone B
    J Biol Regul Homeost Agents; 1999; 13(4):220-4. PubMed ID: 10703946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased serum levels of interleukin-17, interleukin-23, TGF-β in pemphigus vulgaris patients, and their association with disease phase.
    Gholibeigian Z; Izad M; Daneshpazhooh M; Mortazavi H; Salehi Z; Behruzifar S; Akhdar M; Tavakolpour S; Azizpour A
    Dermatol Ther; 2020 Nov; 33(6):e14071. PubMed ID: 32713112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of interleukin-23 in sera of patients with pemphigus vulgaris.
    Pouralibaba F; Babaloo Z; Pakdel F; Abdollahian T; Pourzare S
    Iran J Immunol; 2012 Dec; 9(4):261-5. PubMed ID: 23268293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris.
    Chams-Davatchi C; Mortazavizadeh A; Daneshpazhooh M; Davatchi F; Balighi K; Esmaili N; Akhyani M; Hallaji Z; Seirafi H; Mortazavi H
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1285-92. PubMed ID: 23062214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
    Firooz A; Ghandi N; Hallaji Z; Chams-Davatchi C; Valikhani M; Karbakhsh Davari M
    Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of interleukin-6 is increased both in active and remission stages of pemphigus vulgaris.
    Narbutt J; Lukamowicz J; Bogaczewicz J; Sysa-Jedrzejowska A; Torzecka JD; Lesiak A
    Mediators Inflamm; 2008; 2008():875394. PubMed ID: 18584045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse.
    Reinisch W; Gasché C; Tillinger W; Wyatt J; Lichtenberger C; Willheim M; Dejaco C; Waldhör T; Bakos S; Vogelsang H; Gangl A; Lochs H
    Am J Gastroenterol; 1999 Aug; 94(8):2156-64. PubMed ID: 10445543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission.
    Kwon EJ; Yamagami J; Nishikawa T; Amagai M
    J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1070-5. PubMed ID: 18410336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.
    Sun A; Wang JT; Chia JS; Chiang CP
    Br J Dermatol; 2005 Jun; 152(6):1187-92. PubMed ID: 15948980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of pemphigus vulgaris.
    Kavusi S; Daneshpazhooh M; Farahani F; Abedini R; Lajevardi V; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine Indexes in Pemphigus Vulgaris: Perception of Its Immunpathogenesis and Hopes for Non-Steroidal Treatment.
    Masjedi M; Esmaeil N; Saffaei A; Abtahi-Naeini B; Pourazizi M; Haghjooy Javanmard S; Asilian A
    Iran J Pharm Res; 2017; 16(3):1223-1229. PubMed ID: 29201111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICAM-1, ELAM-1, TNF-alpha and IL-6 in serum and blister liquid of pemphigus vulgaris patients.
    Alecu M; Alecu S; Coman G; Gălăţescu E; Ursaciuc C
    Roum Arch Microbiol Immunol; 1999; 58(2):121-30. PubMed ID: 11845451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.